Total Funding
64
56
Total FundingGrant raised
Growth Score 64 in past quarter
-4 pts
Heat Score 56 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
68315
T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
Simon J. Ittig: CEO and Co-founder
Christoph Kasper: CSO and Co-founder
About the Company
The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Despite significant advances of classical therapies, there remains a high need for novel and innovative medicines to treat cancer. T3 Pharmaceuticals is dedicated to fill this gap by developing highly specific and efficient treatments
using live bacteria.

